Evidence map›Paper›PMID 42245147›Full record

ArticleACS central science2026

A Return to the Logic-First Spirit of Corey's Retrosynthetic Analysis, Now Implemented in Modern Data-Driven CASP.

Mikhail Kabeshov, Giulia Bergonzini, Ola Engkvist

Abstract readNews
In one paragraph

Article in ACS central science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mikhail KabeshovMolecular AI, Discovery Sciences, R&D, AstraZeneca Gothenburg, Pepparedsleden 1, Mölndal 43183, Sweden.ORCID https://orcid.org/0009-0009-2290-6130
Giulia BergonziniCompound Synthesis and Management, Discovery Sciences, R&D, AstraZeneca Gothenburg, Pepparedsleden 1, Mölndal 43183, Sweden.
Ola EngkvistMolecular AI, Discovery Sciences, R&D, AstraZeneca Gothenburg, Pepparedsleden 1, Mölndal 43183, Sweden.ORCID https://orcid.org/0000-0003-4970-6461

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A higher-level retrosynthesis strategy helps computers search synthesis space more like chemists do, improving route discovery for challenging molecular targets.

Identifiers

PMID42245147
PMCPMC13232869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.